“Exciting” data were presented on emapalumab in the treatment of refractory macrophage activation syndrome (MAS ... and presence of features like fever, lymphadenopathy, eosinophilia, and ...

A 3-month period survey is probably more suitable for ... to other AIDs that share some of their clinical features, such as periodic fever, aphthous, pharyngitis and cervical adenitis syndrome (PFAPA) ...

Autoinflammatory diseases (AIDs) are rare clinical conditions, of which familial Mediterranean fever (FMF) is the most common. Unfortunately, medical curricula and many rheumatological centres do not ...

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

In them, I read the dry, short, and ultimately disappointing entries for rheumatoid arthritis. But I also noticed the entries for “rheumatic fever.” Might there be some correlation? I didn’t recall ...

After hours: March 21 at 7:29:08 PM EDT Loading Chart for PXLW ...

After hours: March 21 at 6:20:36 PM EDT Loading Chart for DTIL ...

Objectives Dopamine-dysregulation syndrome (DDS) is an uncommon complication of the treatment of Parkinson’s disease, characterised by addictive behaviour and excessive use of dopamine medication.